To The Moon

$Helen Of Troy(HELE)$ 🚨 HELE Q1 FY2027: Sales Are Back. Now Comes the Real Test.

Helen of Troy ($HELE) finally delivered something investors have been waiting five quarters to see. Revenue growth is back.

Q1 FY2027 revenue climbed 8.2% to $402.1 million, with organic sales up 7.4% across both business segments. Management also raised its full-year sales outlook, signalling the top-line recovery may finally be taking hold.

But beneath the headline, the investment case is far less convincing.

Adjusted EPS plunged 58.5% to $0.17, operating cash flow swung from +$58.3 million to -$0.6 million, and Beauty & Wellness operating income nearly halved. The headline GAAP EPS of $1.51 was largely driven by a one-time $1.74 gain from the sale of a distribution facility rather than stronger underlying operations.

This quarter marked an important milestone, but it didn’t remove the execution risk.

🐂 Bull Case

🟢 Revenue Finally Turned Positive

After five consecutive quarters of declining sales, both operating segments returned to organic growth.

• Home & Outdoor: +8.8%

• Beauty & Wellness: +6.2%

Revenue and adjusted EPS both exceeded management’s expectations, while the company avoided an impairment charge for the first time in five quarters.

🟢 Balance Sheet Keeps Improving

Debt declined to $716 million from $871 million a year ago, interest expense fell 11%, and net leverage improved to 3.48x. Management remains committed to reducing leverage to around 3.2x by fiscal year-end.

🟢 Pricing Power Holding Up

Retailers have largely accepted price increases despite tariff pressures, allowing sales growth to recover without a significant collapse in gross margins.

🐻 Bear Case

🔴 Revenue Grew. Profitability Didn’t.

Despite generating roughly $30 million of additional revenue, adjusted operating income remained flat as tariffs, inventory costs and customer mix absorbed virtually all of the benefit.

Beauty & Wellness was the biggest concern.

Revenue increased 7%, yet adjusted operating income collapsed 48.2%, leaving operating margins at just 1.8%.

🔴 Cash Flow Flashed the Biggest Warning

This was the quarter’s most important datapoint.

Operating cash flow deteriorated from +$58.3 million to -$0.6 million despite positive reported earnings.

Debt reduction came primarily from the asset sale rather than operating performance. Future deleveraging now depends on management delivering a meaningful cash flow recovery throughout the remainder of FY2027.

🔴 Easier Comparisons Helped Growth

Management acknowledged that part of the revenue rebound reflected easier comparisons following last year’s tariff-related disruption.

That means some of this quarter’s improvement simply reflects shipments returning to normal timing rather than a significant acceleration in underlying consumer demand.

⚖️ My Verdict

⚪ Neutral

The turnaround story finally has tangible evidence supporting it.

Revenue has stabilised.

Debt continues moving lower.

Retailers accepted pricing.

Those are genuine positives.

However, earnings quality remains weak.

Operating cash flow turned negative.

Margins remain under pressure.

Management also raised sales guidance while leaving EPS, EBITDA and free cash flow unchanged, effectively signalling lower profitability despite stronger revenue.

Perhaps the biggest challenge is timing.

Q1 delivered only around 5% of expected full-year adjusted EPS, leaving approximately 95% still dependent on execution over the remaining nine months.

That’s achievable, but it leaves virtually no room for disappointment.

Key Themes to Watch

🔴 Cash Flow Will Decide the Story

Revenue started recovering.

Now cash generation must follow.

Management maintained full-year free cash flow guidance of $85-100 million despite starting the year with negative free cash flow. Investors should focus less on quarterly EPS and far more on whether operating cash flow improves during the next two quarters.

🟢 Osprey Continues Winning Market Share

Strong international demand and continued product innovation helped Home & Outdoor outperform once again, reinforcing Osprey’s leadership within premium technical backpacks.

🟢 Olive & June Remains the Bright Spot

Nail care continues driving Beauty & Wellness through expanding retail distribution.

The next question is whether future growth comes from stronger customer demand or simply adding more retail doors.

⚪ Guidance Quietly Became More Challenging

Management raised revenue guidance while maintaining EPS, EBITDA and free cash flow guidance.

Translation?

Higher sales are no longer expected to generate higher profits.

Commodity inflation, freight costs, tariffs and currency pressures continue weighing on margins despite improving revenue.

Bottom Line

Helen of Troy finally produced something investors have wanted to see for over a year.

Revenue growth has returned.

But stronger sales alone don’t complete a turnaround.

Until higher revenue consistently translates into stronger margins, healthier cash flow and sustainable earnings growth, this remains a “prove it” story rather than a completed recovery.

One fascinating market observation: companies emerging from prolonged revenue declines often experience what analysts call a “false dawn”, where sales recover first while profitability lags. The strongest businesses eventually convert those sales into expanding cash flow. The weakest never do.

HELE has now reached that crossroads.

The next two quarters could determine whether this becomes one of 2027’s genuine turnaround stories or simply another value trap.

❓👉 Do you think HELE is entering the early stages of a sustainable turnaround, or is this simply a temporary rebound helped by easier comparisons and one-off gains?

📢 Don’t miss out! Like, Repost and Follow me for exclusive setups, cutting-edge trends, and insights that move markets 🚀📈 I’m obsessed with hunting down the next big movers and sharing strategies that crush it. Let’s outsmart the market and stack those gains together! 🍀

Trade like a boss! Happy trading ahead, Cheers, BC 📈🚀🍀🍀🍀